A Real-World Registry to Investigate the Performance of LenSx® Laser in Chinese Patients
NCT ID: NCT02396719
Last Updated: 2016-06-06
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
1541 participants
OBSERVATIONAL
2015-03-31
2016-05-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Clinical Evaluation of FLACS With Combination of LenSx® and Centurion®
NCT03479944
Accuracy of LASIK Flaps Created With the LenSx® Femtosecond Laser - A Pilot Study
NCT02575911
Changes Between Lenticule Extraction and Femtosecond Laser-assisted Laser in Situ Keratomileusis
NCT02550353
Clinical Application Comparison of Two Femtosecond Laser Systems
NCT06754358
Comparative Study on Changes in Anterior Chamber Cytokines, Oxidative Stress, and Pupil Size After LenSx and Z8 Femtosecond Lasers
NCT06649799
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
LenSx
Phacoemulsification cataract surgery in at least 1 eye using LenSx® Laser technology
LenSx® Laser
Used for cornea incision, capsulotomy and lens fragmentation during cataract surgery
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
LenSx® Laser
Used for cornea incision, capsulotomy and lens fragmentation during cataract surgery
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Will undergo LenSx® Laser-assisted cataract surgery and phacoemulsification in at least one eye;
* Must sign written informed consent;
Exclusion Criteria
* Pregnant, nursing, or planning a pregnancy;
* Concurrent enrollment in another investigational drug and/or device study or participation in such a study within 30 days prior to surgery day;
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Alcon Research
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Zuojun Gao, Medical Affairs Director
Role: STUDY_DIRECTOR
Alcon China
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Alcon China Ophthalmic Product Co., Ltd.
Beijing, , China
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CTO130-P001
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.